Clinical trial Recruiting at 1 site Interventional Ages 28 Weeks to 32 Weeks

Program to enhance feeding in preterm infants

Official title: The Effect of the Tactile/kinesthetic Stimulus Program on the Maturation of Sucking Ability in Preterm Infants

Run by Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital · NCT05486663 · Data updated 2026-11-12

This study tests if a special touch program can help preterm infants learn to suck better and leave the hospital sooner.

Quick facts

Study typeInterventional
Ages28 Weeks to 32 Weeks
SexAll
Enrollment80 (estimated)
SponsorEtlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
Academic / other
Locations1 site (Ankara, Eyalet/Yerleşke)
StatusRecruiting
StartedAugust 1, 2022
Main results expectedAugust 1, 2025
Study endsAugust 1, 2025
Registry record updatedNovember 22, 2024
Trial IDNCT05486663 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are preterm infants born between 28-32 weeks of gestation who are stable and have been cleared for oral feeding.

Probably not a fit

Patients with severe asphyxia, congenital anomalies, or unstable vital signs may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of a tactile/kinesthetic stimulus program on preterm infants to improve their transition to full sucking and reduce hospital stay duration. The study involves a randomized controlled design where one group of infants receives tactile/kinesthetic interventions twice daily for 14 days, while a control group does not. The interventions are carefully administered by experienced NICU nurses, ensuring the safety and stability of the infants throughout the process. Measurements of weight and feeding success will be collected to assess the program's effectiveness.

Why it matters

Potential benefit: If successful, this program could significantly improve feeding outcomes and reduce hospital stays for preterm infants.

How similar studies have gone: While tactile/kinesthetic interventions have been explored in various contexts, this specific application in preterm infants is relatively novel and has not been widely tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

* Born between 28-32 weeks of gestation,
* Stable vital signs,
* 1st and 5th minute APGAR score between 6-10,
* Babies who have received mechanical ventilator or continuous positive air pressure (CPAP) or both support after 48 hours have passed after stabilization,
* Does not have an anomaly that will prevent feeding,
* Oral feeding decision has been made,
* Babies of mothers who are willing to breastfeed their babies,
* Babies of parents who volunteered to participate in the study will be taken.

Exclusion criteria

* IUGG,
* Infants with severe asphyxia,
* Babies born with low birth weight according to their gestational week,
* Having an anomaly that will prevent her from feeding,
* Babies with unstable vital signs,
* Babies with congenital anomalies or serious complications
* Infants with intraventricular bleeding.

Dismissal Criteria

• Babies whose oral feeding process is interrupted for more than 1 day due to neonatal problems.

Where it's running

  • Etlık Zubeyde Hanım Kadın Hastalıkları Eğitim Ve Araştırma Hastanesi
    Ankara, Eyalet/Yerleşke, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.